Cardiovascular disease (CVD) risk factors in Kraków and in the whole Poland adult population. Results from the WOBASZ study and Polish arm of the HAPIEE project.
Agnieszka Doryńska(Institute of Cardiology), Andrzej Pająk(Jagiellonian University), Krystyna Kozakiewicz(Medical University of Silesia), Walerian Piotrowski, Krystyna Szafraniec(Jagiellonian University), Jerzy Piwoński(de Duve Institute), Tomasz Zdrojewski(Gdańsk Medical University), Magdalena Kozela(Jagiellonian University), Wojciech Drygas(Medical University of Lodz), Andrzej Tykarski(Poznan University of Medical Sciences), Maciej Polak(Jagiellonian University), Wojciech Bielecki(Medical University of Lodz)
PubMed
January 1, 2015
Cited by 11
Related Papers
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
|The Lancet|2024|873
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
|The Lancet|2014|713
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
|The Lancet Diabetes & Endocrinology|2016|391